Institutional Ownership Oramed Pharmaceuticals Inc. (ORMP)
This table provides information about the institutional ownership of Oramed Pharmaceuticals Inc. (ORMP). We have compiled data on the 53 institutions that hold shares in the stock, with a total of 7.66 Million shares, which have been reported (via 13F filing form) to have a value of $18.2 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Time Scale Financial, Inc.
|
Jul 26, 2023 Q2 2023 |
125
shares
|
$297
0.0% of portfolio
|
Q3 2020
Added 48.81%
|
|
|
Citigroup Inc
|
Nov 10, 2025 Q3 2025 |
4
shares
|
$9
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|